This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.01519-07v1 46/4/1268    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pas, S. D. Articles by Niesters, H. G. M. Search for Related Content PubMed PubMed Citation Articles by Pas, S. D. Articles by Niesters, H. G. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2008, p. 1268-1273, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.01519-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Comparison of Reverse Hybridization, Microarray, and Sequence Analysis for Genotyping Hepatitis B Virus

Suzan D. Pas,^1* Nathalie Tran,² Robert A. de Man,³ C. Burghoorn-Maas,¹ Guy Vernet,² and Hubert G. M. Niesters^1,

Department of Virology,¹ Gastroenterology, Erasmus MC University Medical Centre Rotterdam, The Netherlands,³ bioMérieux, Lyon, France²

Received 30 July 2007/ Returned for modification 12 October 2007/ Accepted 7 February 2008

Hepatitis B virus (HBV) genotyping has become important in epidemiological and clinical diagnoses, given the relationship between the viral genotype and the progression of disease or the appearance of antiviral resistance. Since genotyping by sequence and phylogenetic analyses is not convenient in the clinical setting, we evaluated InnoLipa HBV genotyping (Innogenetics, Belgium) and an HBV DNA-Chip (bioMerieux, France) prototype assay and compared their sequencing of the gold standard S gene, using a cohort of 275 individual patient samples. All but two samples, belonging to distant and individual subgroups within a single genotype, were detected by InnoLipa HBV assay. Four samples with dual infections belonging to genotypes A and G were identified only by InnoLipa HBV assay. Using an HBV DNA-Chip assay, one sample could not be amplified due to a low viral load. Four samples were identified as genotype C and two as genotype D by sequencing but were classified as genotype A (two samples) and D (two samples) and as A (one sample) and G (one sample) by the DNA-Chip assay. In conclusion, the InnoLipa HBV genotyping strip assay detected dual infections and was an easy and quick tool for genotyping, with a sensitivity of 99.3% and a specificity of 100% compared to sequence analysis. HBV DNA-Chip assay showed a sensitivity and specificity of 97.5 and 97.8%, respectively.

Published ahead of print on 20 February 2008.

Current address: University Medical Centre Groningen, Department of Medical Microbiology, Section of Clinical Virology, Room 2.040, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Phone: 31-50 361 5060. Fax: 31-50 363 3528. E-mail: H.G.M.Niesters{at}mmb.umcg.nl.

This article has been cited by other articles:

• Osiowy, C., Gordon, D., Borlang, J., Giles, E., Villeneuve, J.-P. (2008). Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada. J. Gen. Virol. 89: 3009-3015 [Abstract] [Full Text]